nafamostat has been researched along with Edema, Pulmonary in 2 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sendo, T | 1 |
Itoh, Y | 1 |
Goromaru, T | 1 |
Sumimura, T | 1 |
Saito, M | 1 |
Aki, K | 1 |
Yano, T | 1 |
Oishi, R | 1 |
Naka, Y | 1 |
Hirose, H | 1 |
Matsuda, H | 1 |
Nakano, S | 1 |
Shirakura, R | 1 |
Kawaguchi, A | 1 |
Miyamoto, Y | 1 |
Miyagawa, S | 1 |
Fukushima, N | 1 |
Kawashima, Y | 1 |
2 other studies available for nafamostat and Edema, Pulmonary
Article | Year |
---|---|
A potent tryptase inhibitor nafamostat mesilate dramatically suppressed pulmonary dysfunction induced in rats by a radiographic contrast medium.
Topics: Animals; Benzamidines; Contrast Media; Dose-Response Relationship, Drug; Guanidines; Humans; Male; P | 2003 |
Prevention of pulmonary edema in autoperfusing heart-lung preparation by FUT-175 and leukocyte depletion.
Topics: Animals; Benzamidines; Complement Inactivator Proteins; Dogs; Guanidines; Heart; Isotonic Solutions; | 1989 |